NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.61 Billion CNY | 107.08% |
| 2022 | 5.6 Billion CNY | -13.69% |
| 2021 | 6.49 Billion CNY | 5.8% |
| 2020 | 6.14 Billion CNY | 94.13% |
| 2019 | 3.16 Billion CNY | 4.15% |
| 2018 | 3.03 Billion CNY | -39.86% |
| 2017 | 5.05 Billion CNY | 185.59% |
| 2016 | 1.76 Billion CNY | 0.37% |
| 2015 | 1.76 Billion CNY | -50.21% |
| 2014 | 3.54 Billion CNY | 7.7% |
| 2013 | 3.28 Billion CNY | 36.92% |
| 2012 | 2.4 Billion CNY | -6.98% |
| 2011 | 2.58 Billion CNY | 18.46% |
| 2010 | 2.17 Billion CNY | 17.43% |
| 2009 | 1.85 Billion CNY | 38.05% |
| 2008 | 1.34 Billion CNY | 23.37% |
| 2007 | 1.08 Billion CNY | 20.0% |
| 2006 | 907.69 Million CNY | -1.65% |
| 2005 | 922.89 Million CNY | -0.16% |
| 2004 | 924.39 Million CNY | 12.97% |
| 2003 | 818.25 Million CNY | 79.62% |
| 2002 | 455.55 Million CNY | 59.3% |
| 2001 | 285.97 Million CNY | -12.51% |
| 2000 | 326.87 Million CNY | 62.21% |
| 1999 | 201.51 Million CNY | 12.74% |
| 1998 | 178.75 Million CNY | 72.96% |
| 1997 | 103.35 Million CNY | -1.11% |
| 1996 | 104.51 Million CNY | 2.99% |
| 1995 | 101.48 Million CNY | 9.93% |
| 1994 | 92.31 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 13.02 Billion CNY | 12.11% |
| 2024 Q2 | 10.53 Billion CNY | -19.13% |
| 2024 Q3 | 12.13 Billion CNY | 15.25% |
| 2023 Q1 | 8.4 Billion CNY | 49.81% |
| 2023 Q4 | 11.61 Billion CNY | 41.43% |
| 2023 Q3 | 8.21 Billion CNY | -7.32% |
| 2023 Q2 | 8.86 Billion CNY | 5.45% |
| 2023 FY | 11.61 Billion CNY | 107.08% |
| 2022 Q3 | 7.22 Billion CNY | 0.58% |
| 2022 Q1 | 6.66 Billion CNY | 2.58% |
| 2022 FY | 5.6 Billion CNY | -13.69% |
| 2022 Q4 | 5.6 Billion CNY | -22.31% |
| 2022 Q2 | 7.17 Billion CNY | 7.66% |
| 2021 Q2 | 6.83 Billion CNY | -12.52% |
| 2021 Q1 | 7.81 Billion CNY | 27.17% |
| 2021 FY | 6.49 Billion CNY | 5.8% |
| 2021 Q4 | 6.49 Billion CNY | -4.07% |
| 2021 Q3 | 6.77 Billion CNY | -0.87% |
| 2020 FY | 6.14 Billion CNY | 94.13% |
| 2020 Q1 | 6.32 Billion CNY | 99.81% |
| 2020 Q2 | 5.62 Billion CNY | -11.11% |
| 2020 Q3 | 6.25 Billion CNY | 11.26% |
| 2020 Q4 | 6.14 Billion CNY | -1.76% |
| 2019 Q2 | 5.24 Billion CNY | 36.57% |
| 2019 Q4 | 3.16 Billion CNY | -45.19% |
| 2019 Q3 | 5.77 Billion CNY | 10.15% |
| 2019 Q1 | 3.83 Billion CNY | 26.33% |
| 2019 FY | 3.16 Billion CNY | 4.15% |
| 2018 Q3 | 4.07 Billion CNY | -18.89% |
| 2018 FY | 3.03 Billion CNY | -39.86% |
| 2018 Q4 | 3.03 Billion CNY | -25.42% |
| 2018 Q2 | 5.02 Billion CNY | -4.76% |
| 2018 Q1 | 5.27 Billion CNY | 4.39% |
| 2017 Q4 | 5.05 Billion CNY | 1.45% |
| 2017 FY | 5.05 Billion CNY | 185.59% |
| 2017 Q3 | 4.98 Billion CNY | 21.43% |
| 2017 Q2 | 4.1 Billion CNY | 16.61% |
| 2017 Q1 | 3.51 Billion CNY | 98.81% |
| 2016 Q1 | 1.77 Billion CNY | 0.46% |
| 2016 Q3 | 1.35 Billion CNY | -25.32% |
| 2016 FY | 1.76 Billion CNY | 0.37% |
| 2016 Q2 | 1.81 Billion CNY | 2.78% |
| 2016 Q4 | 1.76 Billion CNY | 30.17% |
| 2015 Q2 | 2.66 Billion CNY | -23.29% |
| 2015 Q1 | 3.47 Billion CNY | -1.75% |
| 2015 Q3 | 2.32 Billion CNY | -13.04% |
| 2015 Q4 | 1.76 Billion CNY | -24.03% |
| 2015 FY | 1.76 Billion CNY | -50.21% |
| 2014 FY | 3.54 Billion CNY | 7.7% |
| 2014 Q1 | 3.4 Billion CNY | 3.59% |
| 2014 Q2 | 3 Billion CNY | -11.71% |
| 2014 Q3 | 3.02 Billion CNY | 0.71% |
| 2014 Q4 | 3.54 Billion CNY | 16.92% |
| 2013 Q1 | 2.65 Billion CNY | 10.7% |
| 2013 Q2 | 3.04 Billion CNY | 14.69% |
| 2013 Q3 | 3.23 Billion CNY | 6.18% |
| 2013 Q4 | 3.28 Billion CNY | 1.57% |
| 2013 FY | 3.28 Billion CNY | 36.92% |
| 2012 Q2 | 3.01 Billion CNY | 15.54% |
| 2012 Q3 | 2.81 Billion CNY | -6.67% |
| 2012 Q4 | 2.4 Billion CNY | -14.65% |
| 2012 FY | 2.4 Billion CNY | -6.98% |
| 2012 Q1 | 2.6 Billion CNY | 1.07% |
| 2011 Q2 | 2.27 Billion CNY | -0.16% |
| 2011 Q4 | 2.58 Billion CNY | 5.8% |
| 2011 Q3 | 2.43 Billion CNY | 7.05% |
| 2011 Q1 | 2.28 Billion CNY | 4.76% |
| 2011 FY | 2.58 Billion CNY | 18.46% |
| 2010 FY | 2.17 Billion CNY | 17.43% |
| 2010 Q4 | 2.17 Billion CNY | 7.7% |
| 2010 Q1 | 2.04 Billion CNY | 10.41% |
| 2010 Q3 | 2.02 Billion CNY | 6.49% |
| 2010 Q2 | 1.89 Billion CNY | -7.26% |
| 2009 Q2 | 1.54 Billion CNY | 3.66% |
| 2009 FY | 1.85 Billion CNY | 38.05% |
| 2009 Q4 | 1.85 Billion CNY | 9.19% |
| 2009 Q1 | 1.48 Billion CNY | 10.58% |
| 2009 Q3 | 1.69 Billion CNY | 10.29% |
| 2008 Q1 | 1.15 Billion CNY | 5.6% |
| 2008 Q2 | 1.3 Billion CNY | 13.77% |
| 2008 FY | 1.34 Billion CNY | 23.37% |
| 2008 Q3 | 1.34 Billion CNY | 2.51% |
| 2008 Q4 | 1.34 Billion CNY | 0.17% |
| 2007 Q4 | 1.08 Billion CNY | 2.52% |
| 2007 Q3 | 1.06 Billion CNY | -0.97% |
| 2007 Q2 | 1.07 Billion CNY | 6.87% |
| 2007 Q1 | 1 Billion CNY | 10.6% |
| 2007 FY | 1.08 Billion CNY | 20.0% |
| 2006 FY | 907.69 Million CNY | -1.65% |
| 2006 Q1 | 857.79 Million CNY | -7.05% |
| 2006 Q2 | 967.39 Million CNY | 12.78% |
| 2006 Q3 | 925.29 Million CNY | -4.35% |
| 2006 Q4 | 907.69 Million CNY | -1.9% |
| 2005 FY | 922.89 Million CNY | -0.16% |
| 2005 Q4 | 922.89 Million CNY | 4.31% |
| 2005 Q3 | 884.71 Million CNY | -2.29% |
| 2005 Q2 | 905.45 Million CNY | -3.08% |
| 2005 Q1 | 934.19 Million CNY | 1.06% |
| 2004 Q1 | 718.9 Million CNY | -12.14% |
| 2004 Q2 | 908.45 Million CNY | 26.37% |
| 2004 Q3 | 912.2 Million CNY | 0.41% |
| 2004 FY | 924.39 Million CNY | 12.97% |
| 2004 Q4 | 924.39 Million CNY | 1.34% |
| 2003 Q2 | 686.89 Million CNY | 28.89% |
| 2003 FY | 818.25 Million CNY | 79.62% |
| 2003 Q4 | 818.25 Million CNY | 19.67% |
| 2003 Q3 | 683.75 Million CNY | -0.46% |
| 2003 Q1 | 532.93 Million CNY | 16.99% |
| 2002 FY | 455.55 Million CNY | 59.3% |
| 2002 Q1 | 304.19 Million CNY | 6.37% |
| 2002 Q2 | 301.79 Million CNY | -0.79% |
| 2002 Q3 | 354.5 Million CNY | 17.47% |
| 2002 Q4 | 455.55 Million CNY | 28.5% |
| 2001 Q4 | 285.97 Million CNY | 0.0% |
| 2001 Q2 | 302.87 Million CNY | 0.0% |
| 2001 FY | 285.97 Million CNY | -12.51% |
| 2000 Q4 | 326.87 Million CNY | 0.0% |
| 2000 FY | 326.87 Million CNY | 62.21% |
| 2000 Q2 | 357.96 Million CNY | 0.0% |
| 1999 Q2 | 186.85 Million CNY | 0.0% |
| 1999 Q4 | 201.51 Million CNY | 0.0% |
| 1999 FY | 201.51 Million CNY | 12.74% |
| 1998 Q2 | 163.63 Million CNY | 0.0% |
| 1998 FY | 178.75 Million CNY | 72.96% |
| 1998 Q4 | 178.75 Million CNY | 0.0% |
| 1997 FY | 103.35 Million CNY | -1.11% |
| 1997 Q4 | 103.35 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 104.51 Million CNY | 0.0% |
| 1996 FY | 104.51 Million CNY | 2.99% |
| 1995 Q4 | 101.48 Million CNY | 0.0% |
| 1995 FY | 101.48 Million CNY | 9.93% |
| 1994 FY | 92.31 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | -15352.352% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.33 Billion CNY | -771.589% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | -1021.183% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 405.85 Million CNY | -2762.266% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -38791.528% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 114.76 Million CNY | -10021.878% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 291.35 Million CNY | -3887.003% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 150 Million CNY | -7644.347% |